Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature Medicine|November 20, 2003
Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunityUrs Eriksson, Romeo Ricci, Lukas Hunziker, et al.
The Journal of Experimental Medicine|February 5, 2003
Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditisUrs Eriksson, Michael O Kurrer, Ivo Sonderegger, et al.
Protein Engineering, Design & Selection : PEDS|November 1, 2017
Half-life extension using serum albumin-binding DARPin® domainsDaniel Steiner, Frieder W Merz, Ivo Sonderegger, et al.
The Journal of Infectious Diseases|March 18, 2025
Estimated Efficacy of TAK-003 Against Asymptomatic Dengue Infection in Children/Adolescents Participating in the DEN-301 Trial in Asia Pacific and Latin AmericaTarek El Hindi, Maria Theresa Alera, Lulu Bravo, et al.
The Journal of Clinical Investigation|October 4, 2006
VSIG4, a B7 family-related protein, is a negative regulator of T cell activationLorenz Vogt, Nicole Schmitz, Michael O Kurrer, et al.
Bioanalysis|November 14, 2024
Harmonization of Vaccine Ligand Binding Assays ValidationFrancis Dessy, Ivo Sonderegger, Leslie Wagner, et al.
Bioanalysis|June 22, 2026
Vaccine Ligand Binding Assay Life Cycle Management, Assay Maintenance, Monitoring and TransferJeroen Stoop, James Huleatt, Luc Gagnon, et al.
Bioanalysis|February 3, 2021
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (Part 3 - Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays)Bart Corsaro, Tong-Yuan Yang, Rocio Murphy, et al.
Bioanalysis|February 23, 2024
2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard (Part 3 - Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Biotherapeutics Immunogenicity & Risk Assessment; ADA/NAb Assay/Reporting Harmonization)Johanna Mora, Rachel Palmer, Leslie Wagner, et al.
Bioanalysis|May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (Part 3 - Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)Lina Loo, Shannon Harris, Mark Milton, et al.
Pageof 3